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The herbal cosmetics are prepared by phytochemicals that occur in a variety of botanical sources, that influences the physiology of skin and provide 
nutrients that are necessary for the healthy skin or hair. These products are utilized for daily purposes, which include herbal shampoo, herbal 
conditioner, herbal face wash, herbal soap, etc. These products are classified as a different category by regulatory agencies. However, guidelines of 
these certifying agencies have no harmonization, and many cosmetic industries prepare and package these formulations in an irrationalway. Many 
cosmetic products have natural products in their formulation that perform a specific biological function, but these products should be evaluated on 
their toxicological and efficacy aspects. The contribution of developing countries is very poor in global herbal business because of lack of 
standardization measures and quality control. The lack of safety and efficacy data on herbal cosmetics renders it difficult to meet the criteria needed 
for supporting its use worldwide. This review article discusses challenges related to regulatory status, quality control, standardization, certification, 
drug processing and the opportunities for herbal cosmetics in local as well as the global scenario. The search criteria used in the present review 
were the keywords mentioned in the manuscript and articles from major scientific resources were cited. The articles from 1952 to 2018 were 
specifically referred, but few references from 19 century were also cited to support the prevalence of scientific principles in the development of 
herbal cosmetics in the ancient era. 
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The cosmetics, according to the Drugs and Cosmetics Act is defined 
as articles intended to be rubbed, poured, sprinkled or sprayed on, 
introduced into or otherwise applied to the human body or any part 
thereof for cleansing, beautifying, promoting attractiveness or 
altering the appearance. The cosmetic does not come under the 
preview of the drug license [1]. The natural herbs and their products 
when utilized for their sweet-smelling an incentive in corrective 
planning are named as natural beautifying agents [2]. There is the 
regular conviction that compound based beautifiers are destructive 
to the skin and expanded mindfulness among consumers for natural 
extracts set off the interest for common items and normal 
concentrates in beautifying agents arrangements [3, 4]. According to 
the United States, Food and Drug Administration (US FDA), the Food, 
Drugs, and Cosmetics Act; A product can be a drug, a cosmetic, or a 
combination of both, but the term "Cosmeceuticals" has no meaning 
under the law" [5]. So, the term Cosmeceuticals is not recognized by 
the Federal Food, Drug, and Cosmetic Act. In spite of the fact that 
beauty care products and Cosmeceuticals are tried for wellbeing, 
testing to decide if valuable fixings satisfy a manufacturer’s cases 
isn't required [6]. When all is said in done, vitamins, herbs, different 
oils, and organic concentrates might be utilized as a part of 
Cosmeceuticals, however, the manufacturer may not assert that 
these items penetrate the skin's surface layers or that they have 
therapeutic effects [7, 8]. A major factor impeding the development 
of the medicinal plant-based industries in developing countries has 
been the lack of information on the social and economic benefits that 
could be derived from the industrial utilization of medicinal plants. 
Except for the use of these plants for local health care needs, not much 
information has been available on their market potential and trading 
possibilities. These challenges in formulating a herbal cosmetic or a 
product, in general, are being discussed in this article [9, 10]. 
History 
The word cosmetic was derived from the Greek word “kosmtikos” 
meaning having the power, arrange, skill in decorating [11]. The 
word cosmetics defined as “Substances of diverse origin, 
scientifically compounded and used to i) cleanse, ii) allay skin 
troubles, iii) cover up imperfections and iv) beautify”. The origin of 
cosmetics forms a continuous narrative throughout the history of 
man as they developed. This origin of cosmetics was associated with 
chasing, battling, religion and superstition and later connected with 
medicine [12]. The man in ancient circumstances utilized hues for 
improvement to draw in the creatures that he wished to chase, and 
the man survived an assault from the adversary by shading his skin 
and embellished his body for insurance to incite fear in a foe 
(regardless of whether man or creature) [13]. Ashtanga Hridaya (a 
1500-year-old book of Ayurveda) offers six unique plans to be 
utilized for the six periods of the year. 
Special Tailams (Oils) and Ghritas (Clarified spread or ghee) were 
utilized for facial beautification. Unnecessary hair was thought to be 
a disgrace, and a substantial number of depilatory specialists were 
prescribed to dispose of it. Special ingredients were utilized for hair 
washes [14]. Numerous cures have been demonstrated for hair 
development, the counteractive action of falling hair and untimely 
turning grey [15]. Hair colours, fragrant hair washes, and fumigants 
were likewise being used. Fragrant shower powders and body 
antiperspirants were additionally used [16]. 
Oral cleanliness as care of teeth, mouth antiperspirants and shading 
of lips were everyday errands to be religiously sought after [17]. It 
gives the idea that the full scope of present-day corrective use was 
brought about by the ancient Indians and was rehearsed with the 
assistance of natural products that were available [18]. 
The information at last separated from drug lastly to pharmacy. The 
man from ancient time had the magic tip towards impressing others 
with their look. The time during which there was no fairness creams 
or any cosmetics surgeries to modify the appearance, the skin and 
hair excellence of people relies upon the wellbeing, propensities, 
routine employment, climatic conditions and support. The skin 
because of exorbitant introduction to warmth will get dried out amid 
summer and causes wrinkle, spots, flaws, pigmentation and 
sunburns. The outrageous winter make harms the skin as breaks, 
cuts, maceration, and contaminations [19-22]. 
The main factor they needed to depend on was the information of 
nature arranged in the Ayurveda. The art of Ayurveda had used 
numerous herbs and verdures to make beauty care products for 
beautification and security from outside influences [23]. The normal 
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substance in the botanicals does not bring about any reactions on 
the human body; rather enhance the body with supplements and 
other helpful minerals [24]. 
The Drug and Cosmetics Act indicate that herbs and basic oils 
utilized as a part of beautifying agents must not claim to enter past 
the surface layers of the skin nor ought to have any helpful impact 
[25]. The lawful prerequisite and the administrative techniques for 
natural beauty care products are the same as that for other synthetic 
chemicals utilized as a part of cosmetic formulations [26]. 
Challenges 
Ethnic Factors 
It includes the factors that affect the nature of the drug at the time of 
cultivation of herbs. 
• Light 
• Temperature 




Any variations in the above factors affect the nature of the drug 
resulting in the alteration of the number of active constituents 
present in the herbs which becomes challenging while formulating 
herbal cosmetics. 
Regulatory status of herbal drugs 
WHO guidelines state that both manufacturers and regulatory 
bodies should share equal responsibility to assure the quality of 
herbal products [32]. It is the duty of regulatory authorities to 
establish some ground guidelines on various aspects of quality 
assurance, data evaluation, dossiers and evaluation of post-
marketing compliance of products with the specifications set out by 
the manufacturers as well to comply with GMP guidelines [33-35]. 
It is of chief importance that the manufacturers firmly stick to good 
agricultural and further good collection practices (GACP), GMP and 
good laboratory practice (GLP) standards, to establish proper 
specifications for their finished products, raw materials, and 
intermediates and to gather whole documentation on the herbal 
development and testing. The producers must keep in pace with the 
current information with respect to manufacturing and marketing of 
products [36]. 
In WHO summit in 2000, several recommendations for quality 
control of farming of raw materials of herbal formulations were put 
forth. During this summit, it was recommended that a sub-
committee should be formed on GACP to make sure superior quality 
of herbal products are made available to the market by providing 
proper training to small manufacturers and farmers [37]. 
For the implementation of GACP, incentives can be given to 
manufacturers of raw materials. These incentives take in 
consideration giving technical and logistic support in the selection of 
suitable areas for the agricultural purpose, giving appropriate seeds 
and seedlings, selecting pesticides and fertilizers, providing advice 
on equipment for harvesting, and further processing [38]. 
The national drug regulatory authority should safeguard the issue of 
license for manufacturers, wholesalers, importers, and assemblers of 
herbal medicinal [39]. One or more licences are needed to be applied 
by the dealers of imported herbal products depending on the type of 
business involved [40]. 
One of the departments that ensure the quality of the products by 
following well-organized and standard specifications is Quality 
Control. These standard specifications can be found in official 
pharmacopoeia, monographs, etc. Many analytical techniques are 
used to check the quality of herbal products. Detailed information of 
the herbal products with a list of all ingredients, formula of the 
product for imported herbal-based products for the registration of 
herbal products [41-43]. The details of manufacturer(s) and their 
licence or certificate from the drug regulatory authority, brand name 
of product, dosage form and dosage, indications, administration 
mode, duration of use, adverse effects, any contraindications, 
warnings, important precautions, lot/batch number, and any 
possible drug interactions, manufacturing and expiry date of the 
product and conditions for storage. To assess and gather data about 
the safety and efficacy of herbal products simultaneously watching 
for adverse drug reactions, pharmacovigilance centres are required 
[45-47]. 
Product certification 
The main objective of the certification of a product is to check the 
ingredients including raw materials, processes, production and 
manufacturing, raw materials storage, packaging and labelling, 
energy resources usage and waste disposal management, also the 
certification of manufacturers to certify the quality of the end 
product. The certification agencies execute standards that should be 
satisfied by the manufacturer, to be able to ensure the quality of the 
final product [48]. 
The major certification agencies for natural and organic 
products are 
1. Bundesverb and Deutscher Industrie und Handel 
sunternehmen (BDIH) in Germany: BDIH is the non-governmental 
association of Trading Firms and industries for pharmaceuticals, 
food supplements, health care products, and personal care products. 
This is located in Mannheim, Germany and has organized over 440 
distributors and producers of:  
- Cosmetics and Natural Cosmetics 
- Nutritional and Food supplements 
- OTC Medications 
- Medical Devices 
2. Soil association organic standard in the United Kingdom: 
The Soil Association is based on a charitable trust in the UK, which 
was found in 1946. It has about 27,000 members. Its activities 
contain campaign work on concerns including backing for local 
purchasing. It opposes the intensive farming. And gives training on 
nutrition and the certification of organic food. 
3. Cosmetics organic standard (Cosmos) in European Union (EU): 
The COSMOS standard is owned and organized by an international non-
profit and non-governmental organization which is registered in 
Belgium. Its main objective is to guard the welfare of the environment 
and of people, in cosmetics. The COSMOS standards simulate the 
development of cosmetics that are ever more organic and assure the 
consumers that they have clear and transparent information. 
4. ECOCERT in france: Ecocert is an association of organic 
certification, found in France in 1991. It is originally based in Europe 
but examines in over 80 countries, which makes it one of the major 
organic certification organizations in the world. 
5. National association for sustainable agriculture, australia 
(NASAA) in australia: It was formed in 1986, which is a non-profit 
membership based organization, whose contract is "to maintain the 
education of industry and customers on organic, sustainable and 
biodynamic agricultural practices”. 
6. Istituto per la certificazione etica e ambientale (ICEA) in 
Italy: It is an independent and qualified Certification Institute which 
is a non-profit consortium consisting of experts in panels and 
certifications concerned with ethical standards and ecological 
sustainability. 
7. Instituto Biodinâmico de Certificações (IBD) in Brazil: IBD is 
the chief certifier in Latin America and the only Brazilian certifier of 
natural products with USDA/NOP (North American market), IFOAM 
(international market), Demeter (international market), European 
market-regulation and permitted for usage of the SISORG, a Brazilian 
market seal, which makes its certificate accepted globally. 
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8. Oregon Tilth in the United States of America: OTCO is the 
organization for certification program which was established in 
1982 and involves in certification actions for agricultural and 
product manufacturers and other handlers of natural products. 
9. Quality assurance international (QAI) in the united states of 
America: This is a U.S. based international organic 
certification organization that is approved by the United States 
Department Agriculture (USDA) as “a USDA-accredited certifying 
agent that functions globally to certify organic procedures to National 
Organic Program principles." It is a profit corporation which is 
established in 1989 and headquartered in San Diego, California [44-51]. 
Quality control of herbal drugs and cosmetics 
To choose an extracting solvent, the nature of the compounds involved 
should be considered and might be concluded from the traditional uses. 
For example, when a tea is made from a herbal drug, the extractable 
matter from hot water, which is expressed as milligrams per gram of air-
dried material [57]. When the active elements are known, a huge 
collection of modern chemical analytical methods such as HPLC, GC, UV 
or visible spectroscopy (UV/VIS), TLC, mass spectrometry (MS), or a mix 
of GC and MS (GC/MS), can be performed [52]. 
Precision, validity, accuracy, robustness of the equipment plays a major 
role in choosing an analytical method. Availability of sophisticated 
techniques such as HPLC-high-performance liquid chromatography, MS-
mass spectrometry, and GC-Gas chromatography, making it possible to 
find as well as measure the test substance [53, 54]. 
Several factors influence the quality of herbal drugs. They are;  
1. Herbal drugs are a combination of several constituents. 
2. In most cases, the active principle(s) is/are, unidentified. 
3. Analytical methods that are suitable or standard references may 
not be available commercially [55]. 
4. Plant actives are chemically and naturally inconstant. 
5. The raw material source and quality are unstable [56]. 
6. The methods of collecting, drying, storage, transportation, and 
processing have a variable effect on the final product. 
7. Firm guidelines have to be followed for the production of a herbal 
product with superior quality. Proper plant identification, phytochemical 
screening, and standardization can be the criteria to look for [57, 58]. 
It plays a key role in assuring the quality and steadiness of herbal 
products, the quality of a plant product is determined by the 
dominant conditions during development and recognized Good 
Agricultural Practices (GAP) can regulate this [59]. 
These include seed assortment, growth environment, and use of 
fertilizers, reaping, drying and storing. GAP procedures are and will 
be, a vital part of quality regulation [60]. 
Factors such as the usage of new plants, age and part of plant 
gathered, period, time and technique for accumulation, the 
temperature of the process, light introduction, water accessibility, 
supplements, drying, pressing, transportation and capacity of the 
crude material, can incredibly affect the quality [61]. 
Apart from these standards, influences such as the extraction 
method, microbial contamination, presence of heavy metals, and 
pesticides can alter the quality, safety, and efficacy of herbal drugs 
[62]. Using cultivated plants under controlled conditions instead of 
those collected from the wild can minimize most of these factors 
sometimes the active principles are destroyed by enzymes processes 
that continue for prolonged periods from collection to marketing, 
resulting in a variation of composition. Thus, proper standardization 
and quality control of both the raw material and the herbal 
preparations should be conducted [63, 64]. 
Evidence of clinical efficacy 
Scientific evidence from randomized clinical trials is only strong for 
many uses of acupuncture, some herbal medicines and for some of 
the manual therapies. Only a small fraction of the thousands of 
medicinal plants used worldwide has been tested rigorously in 
randomized, controlled trials [65]. Even if the animal studies or 
anecdotal clinical experiences are promising and use of a herb is 
widespread, such observations cannot predict the results of well-
designed randomized, controlled trials. A recent review concluded 
that evidence-based studies on the efficacy and safety of traditional 
Indian medicines are limited. The data available is mostly 
experimental or in animals [66, 67]. 
Standardization 
It involves adjusting the herbal drug preparation to a defined 
content of a constituent or a group of substances with known 
therapeutic activity by adding excipients or by mixing herbal drugs 
or herbal drug preparations [68]. Botanical extracts made directly 
from crude plant material show substantial variation in composition, 
quality, and therapeutic effects. Standardized extracts are high-
quality extracts containing consistent levels of specified compounds, 
and they are subjected to rigorous quality controls during all phases 
of the growing, harvesting, and manufacturing processes. No 
regulatory definition exists for the standardization of dietary 
supplements [69]. 
As a result, the term “standardization” may mean many different 
things. Some manufacturers use the term standardization 
incorrectly to refer to uniform manufacturing practices; following a 
recipe is not sufficient for a product to be called standardized. 
Therefore, the presence of the word “standardized” on a supplement 
label does not necessarily indicate product quality [70]. 
When the active principles are unknown, the marker substance(s) 
should be established for analytical purposes and standardization 
[71, 72]. Marker substances are chemically defined constituents of a 
herbal drug that is important for the quality of the finished product. 
Ideally, the chemical markers chosen would also be the compounds 
that are responsible for the botanical effects in the body [73, 74]. 
There are two types of standardization. In the first category, “true” 
standardization, a definite Phytochemical or group of constituents is 
known to have activity [75]. Ginkgo with its 26% ginkgo flavones 
and 6% terpenes is a classic example. These items don’t represent 
the entire herb and are presently considered as 
phytopharmaceuticals. By and large, they are boundlessly more 
viable than the entire herb [76]. In any case, the procedure may 
bring about the loss of adequacy and the potential for unfavorable 
impacts and herb-drug interactions may increment [77]. The other 
sort of standardization depends on makers ensuring the nearness of 
a specific level of marker aggravates; these are not pointers of 
therapeutic effect or nature of the herb. On account of natural 
medication arrangements, the generation and primary step of the 
medicinal plant or natural medication impacts the nature of the 
APIs, because of the multifaceted nature of normally developing 
therapeutic plants and the constrained accessibility of basic 
explanatory methods. To recognize and portray the dynamic 
constituents exclusively by synthetic or organic means, there is a 
requirement for a satisfactory quality affirmation framework. This 
confirmation is additionally required amid development, gathering, 
essential preparing, capacity, packaging, and distribution [78-80]. 
Deterioration and contamination through adulteration, especially 
microbial contamination, can occur at any one of these stages. It is 
extremely important to establish good agricultural, harvesting, and 
manufacturing practices for herbal starting materials in order to 
minimize this undesirable factor [81]. 
In such manner manufacturers, processors, and traders of therapeutic 
plants or natural medications have a commitment and a part to play. The 
makers and suppliers of natural products should cling to quality control 
standards and GMP‟ well -being via doing re-market surveys of all 
medications previously they are approved available to be purchased. The 
items accessible in the market are investigated routinely to guarantee 
that they are free of harmful ingredients and that the products contain 
ingredients mentioned as such in labels [82, 83]. 
This procedure requires high information in the Phytochemical 
investigation and process innovation to guarantee the quality 
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affirmation required. The expansion of significant worth in natural 
products as numerous procedures inside the phytochemical 
business is comparative or indistinguishable to unit tasks inside the 
synthetic building. It demonstrates the likenesses in unit operations 
and Phytochemical preparing techniques between conventional 
synthetic designing and Phytochemical handling [84-85]. Many areas 
of chemical engineering would be applicable to the phytochemical 
industry. In terms of basic knowledge Chemical engineers need to 
emphasize on acquiring more data on: - 
 Organic Chemistry–Natural products chemistry in particular 
 Analytical Methods–such as HPLC, LC-MS, NMR 
Among key issues that must be tended to incorporate creating 
process plan information for homegrown extraction. Currently, 
much natural extraction configuration is done in light of learning 
from food technologists. Regularly these outline techniques don't 
consider compound thermodynamic information or plan strategies. 
Process models are fabricated are not effectively reproduced or used 
the same number of depending on surface reaction philosophies 
which are just relevant to the gear examined. More first principle 
modeling methods need to be developed to model, optimizes, and 
scale up herbal extraction processes [86-87]. 
Processing and GMP 
There are major processes in natural therapeutic products 
fabricating beginning from natural yield planting to manufacturing 
and advertising. Chemical designers are included once the herb is 
gathered where speedy pre-preparing and stockpiling is required. 
Pre-handling includes diminishing the span of the herb through 
chopping and granulating to get ready for preparing while great 
stockpiling technique guarantees that the dynamic Phytochemicals 
are kept up before handling [88-89]. 
Processing is a basic part of herbal product generation, particularly 
because of the low yield of concentrates. Handling techniques are 
generally in light of conventional strategies, for example, high-
weight water extraction for herbs which are customarily bubbled as 
decoctions. New inventive strategies, for example, Supercritical 
Fluid Extraction (SFE) where supercritical liquids, for example, 
carbon dioxide under high pressure are used to deliver natural 
concentrates should be created to deliver homegrown results of 
higher yield, bring down working expenses, and speedier generation 
times. Packaging and sale take place after processing [90-91]. 
Good Manufacturing Practice (GMP) is a code of training utilized by 
the medical and health-related industries incorporating the 
pharmaceutical business with an end goal to keep up the most 
elevated standards of value in the improvement, manufacture, and 
control of therapeutic products [92]. 
Toxicity of traditional herbal drugs 
Herbs generally can cause either digestive upset or allergic 
reactions. Digestive upset can result from taking some herbs like 
standardized ginkgo extract, especially on an empty stomach. In 
their whole form, herbs have lots of crude fibre and can be tough to 
digest for some people. Herb extracts are often easier to digest and 
usually cause a less digestive upset, though even extracts can cause a 
feeling of nausea or fullness to occur in some cases. Adverse drug 
reactions, allergic reactions, drug interactions, herb-drug 
interactions, contamination of the drug, false authentication of the 
drug are some of the other challenges that come into consideration 
when spoke about herbal cosmetics [93, 94]. 
DISCUSSION 
Herbal Cosmetics are referred to as Products, are formulated, using 
various permissible cosmetic ingredients. Herbal cosmetics are also 
known as “natural cosmetics. The various ingredients which are 
used for herbal cosmetics are Aloe Vera gel, cucumber extract, 
honey, lemon oil, etc. In the formulation of herbal cosmetics mainly 
herbal skin care products, hair care, lip care, eye care, herbal soaps, 
perfumes and oils are included. Quality control is a term that 
referred to processes involved in maintaining the quality and 
validity of the manufactured product. In the evaluation of herbal 
cosmetics, we include microscopic evaluation, determination of ash, 
heavy metals, foreign matter and include micro-skeptical 
contamination etc. The marketing analysis of all herbal cosmetic 
products is very essential to be carried out [95-97]. 
Various marketed herbal cosmetic products are available for skin, 
hairs, lips, eyes etc. herbal cosmetics are more beneficial in the 
cosmetic and therapeutic application than other synthetic cosmetics. 
The herbal cosmetics are defined as which are having various herbal 
ingredients and herbal extracts. The best thing about the herbal 
cosmetics is that it is purely made by the herbs and shrubs [98, 99]. 
Herbal cosmetics are also known as “natural” and “Ayurvedic” 
cosmetics. Natural beauty care products are in presence from when 
the men began to utilize the cosmetic items. In this way, they are the 
most seasoned items utilized by humanity. Some common 
beautifying agents incorporate creams, face packs and scrubs, hair 
oils, hair hues, shampoos, hair conditioners, lipsticks, blush on or 
rouge as it is at times known, eyeliners, mascaras, foundations and 
eyeshadow, perfumes and scent, cleansers, and so forth. The 
detailing of all these restorative items incorporates an expansion of 
different regular added substances like oils, waxes, normal hues, 
common aromas and parts of plants like leaves, blooms and so forth 
by particular definition techniques [100-102]. 
Quality control for the efficacy and safety of herbal cosmetic 
products is of paramount importance. So, quality control test must 
be carried out for herbal cosmetics. Microscopic evaluation is 
indispensable in the initial identification of herbs [103-105]. And 
other evaluations methods for identifying the presence of ash, 
foreign matters, contaminants, heavy metals should be carried out 
for safe and good quality cosmetic products. There are a few 
noteworthy strides in herbal products production beginning with 
herbal yield planting to production and promoting. Increasingly, 
consumers are looking for products which have less impact on the 
environment. Today, the cosmetics are more “eco-friendly”. Certain 
processes on the raw materials used in the formulation of the test 
and the use of the test to evaluate the effectiveness and toxicology 
creating a larger impact on the cosmetic product and this causes the 
search for this type of product by the consumers [106-108]. For 
products to be categorized by natural or organic these guidelines 
and standards established by the regulatory agencies should be 
followed, but there isn’t a harmonization between them. These 
standards are designed to establish the allowed packaging processes 
and propose a sustainable extraction and allowed processes [109-
112]. Various challenges in formulating herbal cosmetics have been 
overcome through various novel delivery systems [113-114]. 
CONCLUSION 
Formulating natural or organic cosmetics is the challenge to 
guarantee stability, safety, and efficiency. On the other hand, there is 
no harmonization of the guidelines related to regulatory 
perspectives. Many natural products can be used in cosmetic 
products which perform a biological function. The use of plants and 
herbs tends to increase in the market of cosmetic products with 
more sustainable market share. Therefore, there is a need for 
harmonized standards for herbal cosmetic products and the 
standardization of raw materials. 
AUTHORS CONTRIBUTIONS 
All the author have contributed equally 
CONFLICTS OF INTERESTS 
The authors do not have any conflicts of interest 
REFERENCES 
1. Joshi H. Potentials of traditional medicinal chemistry in the 
cosmetology industry; prospective and perspectives. 
Anaplastology 2012;1:3. 
2. Sahu AN, Jha S, Dubey SD. Formulation and evaluation of 
curcuminoid based herbal face cream. Indo Global J Pharm Sci 
2011;1:77-84. 
3. Pandey S, Meshya N, Viral D. Herbs play an important role in 
the field of cosmetics. Int J Pharm Tech Res 2010;2:632-9. 
Jain et al. 
Int J App Pharm, Vol 10, Issue 6, 2018, 47-53 
 
51 
4. Gediya SK, Mistry RB, Patel UK, Blessy M, Jain HN. Herbal plants: 
used as cosmetics. J Nat Prod Plant Resour 2011;1:24-32. 
5. Saha R. Cosmeceuticals and herbal drugs: practical uses. Int J 
Pharm Res Allied Sci 2012;3:59-65. 
6. Sharma HD, Paramesh R. Trends in ageing and skin care: 
Ayurvedic concepts. J Ayurveda Integr Med 2010;1:110–3. 
7. Top 7 Advantages of using Natural Cosmetics. Available from: 
www.thenewecologist.com. [Last accessed on 12 Nov 2018] 
8. Akinyele BO, Odiyi AC. Comparative study of the vegetative 
morphology and the existing taxonomic status of Aloevera
9. Escamilla M, Ferre A, Hidalgo C, Fuentes N, Kaps R. Revision of 
European ecolabel criteria for soaps, shampoos and hair 
conditioners. Joint Res Centre Eur Commission Int J Pharm Sci 
2012;8:1-40. 
. J 
Plant Sci 2007;2:558-63. 
10. Suzuki D. The “Dirty Dozen” Ingredients Investigated in the 
David Suzuki Foundation Survey of Chemicals in Cosmetics; 
2010;1-15. Available from: https://davidsuzuki.org/wp-
content/uploads/2017/10/dirty-dozen-cosmetics-ingredients-
backgrounder.pdf. [Last accessed on 01 Dec 2017] 
11. Database. On occupational exposure to hazardous agents. 
Available from: https://coldwarpatriots.org/database-of-
occupational-exposure-to-hazardous-agents-hazmap/. [Last 
accessed on 02 Dec 2017]. 
12. International Agency for Research on Cancer (IARC) Monographs 
on the Evaluation of Carcinogenic Risks to Humans 1978;84:1-
365.  
13. Kadam VS, Chintale AG, Deshmukh KP, Nalwad 
DN. Cosmeceuticals an emerging concept: a comprehensive 
review. Int J Res Pharm Chem  2013;3:308-16.
14. Winter RA. Consumers dictionary of cosmetic ingredients. Three 
Rivers press United states USA. 7th ed.; 2009. Available from: 
https://www.amazon.com/Consumers-Dictionary-Food-
Additives-7th/dp/0307408922. [Last accessed on 21 Nov 2017] 
15. Upadhyaya SC. Ratirahasya (13th
16. Bhishagaratna KL. An english translation of sushruta-samhita 
(176-340 A. D)–the chokhamba sanskrit series office, 
Varanasi: Chapter 20:37.5.; 1963. p. 455. 
 Cen A. D.) Mumbai: D. R. 
Taraporevala Sons and Co. Pri. Ltd; 1965. p. 96. 
17. Bhishagaratna KL. Atridev-vagbhat.-ashtang hridaya-shri 
vagbhatvirachita (Later half of 5th
18. Sharma T. Nagarasarvaswam-padmashrivirachit (10thCen. A. D.) 
manilal desai, Fort, MumLad GP. Archeology and Mahabharata. 
Pune: Deccan College Postgraduate Research Institute; 1978.  
Cen A. D.) Varanasi: 
Chaukhamba Sanskrit Series Office; 1962. 
19. Patkar KB, Bole PV. Herbal cosmetics in ancient India with a 
treatise on planta cosmetic. Bharatiya Vidya Bhavan Mumbai, 
India Mumbai: World Wide Fund for Nature; 1997. 
20. Rao SA. Sri Sarabhendra Vaidya Ratnavali. In: Krishnaswami 
Mahadick. editor. Saraswati Mahal Library: Tanjore; 1952. p. 
277, 351, 4, 9, 81. 
21. Mukerji B. The Indian pharmaceutical codex-council of 
scientific and industrial research. Council of Scientific and 
Indrustrial Research. Vol. 1. New Delhi; 1953. p. 223-8. 
22. Rao SA. Sri sarabhendra vaidya ratnavali. In: 
23. Watson JF. Index to the native and scientific, names of 
economic plants. In: Eyre GE, Spottiswoods W. editors. London; 
1866. p. 412. 
Krishnaswami 
Mahadick. editor. Saraswati Mahal Library: Tanjore; 1952. p. 
277, 351, 354, 359, 381. 
24. Anon. Maharashtra State Gazetteer. Vol. A. Mumbai: Bot Gen 
Miscellaneous Plants-Govt Printing Press; 1961. p. 84. Part III. 
25. Mishra J. Shri Kamaratnam-Nityanathvirachitam (13th Cent. A. D.) 
Kalyan, Lakshmi Venkatesswar Prakashan: Mumbai; 1897. p. 93. 
26. Lal BB. The Saraswati flows on: The Continuity of Indian 
Culture; 2002. 
27. Mahabharata. Bhandarkar oriental research institute. 
 Viratparva. Chap.3:17, 8:16, Aadiparva. Chap. 213:44. 
28. Lad GP. Archeology and Mahabharata. Pune: Deccan college 
postgraduate research institute; 1978. 
29. Notes of Guidance for Testing of Cosmetic Ingredients for Their 
Safety Evaluation. 4th
30. Oakland JS. Management tools in the manufacture of chemicals: 
statistical quality control. Chem Ind 1981;16:562-7. 
 rev; 2000. Available from: 
https://ec.europa.eu/health/scientific_committees/consumer_
safety/docs/sccs_s_006.pdf. [Last accessed on 04 Dec 2017]. 
31. Pierre M. Sampling of particulate materials theory and practice. 
2nd
32. Sommer K. Sampling of powders and bulk materials. Heidelberg, 





RC2KFNOVzx5X-yeJw#v=onepageandqandf=false. [Last accessed 
on 07 Jan 2017] 
ed. New York; 1979. 
33. Sampling procedures for inspection by attributes. Procedures for 
assessment of stated quality levels. British Standard BS 6001-
5:2000. Geneva, International Organization for Standardization; 
1999. Available from: http://www.who.int/ medicines/areas/ 
quality_safety/quality_assurance/GuidelinesSamplingPharmPro
ductsTRS929Annex4.pdf [Last accessed on 21 Jan 2018] 
34. Sampling procedures for inspection by variables. Specification 
for single sampling plans indexed by acceptable quality level 
(AQL) for lot-by-lot inspection. British Standard BS 6002-1. 
Geneva, International Organization for Standardization; 1989. 
Available from: https://www.iso.org/standard/9602.htm. 
[Last accessed on 21 Nov 2018] 
35. Sampling procedures for inspection by attributes. Sampling 
schemes indexed by acceptance quality limit for lot-by-lot 
inspection. British Standard BS 6001-1. Geneva, International 
Organization for Standardization; 1999. p. 2859-1. Available 
from: https://www.iso.org/obp/ui/#iso: std: iso: 2859:-1:ed-
2:en. [Last accessed on 20 Dec 2017] 
36. American National Standards Institute/American Society for 
Quality. Sampling procedures and tables for inspection by 
attributes. Washington, DC, American Society for Quality; 1993 
Available from: http://vcg1.com/files/ANSI_ASQC-Z1.4. pdf. 
[Last accessed on 02 Nov 2017] 
37. Methods for sampling chemical products. Introduction and 
general principles. British Standard BS 5309-1. London, British 
Standards Publishing; 1976. Available from: 
www.who.int/medicines/areas/quality_safety/./QualityAssura
ncePharmVol2.pdf. [Last accessed on 26 Jan 2018] 
38. Methods for sampling chemical products. Sampling of liquids. 
British Standard BS 5309-3. London, British Standards 
Publishing; 1976. Available from: www.who.int/medicines/ 
areas/quality_safety/./QualityAssurancePharmVol2.pdf. [Last 
accessed on 22 Jan 2018] 
39. US Food and Drug Administration. Guidance for Industry: 





accessed on 23 Jan 2018] 
Geneva, Switzerland: World Health Organization Operational 
Guidance: Information Needed to Support Clinical Trials of Herbal 
Products. (Document reference (who/TDR/GEN/Guidance/051); 
2005. 
41. Acceptance sampling plans and procedures for the inspection of 
bulk materials. Geneva, International Organization for 
Standardization; 2000. Available from: https://www.iso.org/ 
standard/33418.html. [Last accessed on 14 Nov 2017] 
Available from: www.who.int/tdr/publications/tdr-
research-publications/operational-guidance/en/. [Last accessed 
on 21 Dec 2017] 
42. Ernst E, Siev-Ner I, Games D. Complementary medicine-a 
critical review. Isr J Med Sci 1997;33
43. 
:808-15. 
Kleinman A, Eisenberg L, Good B. Culture, illness, and care: 
clinical lessons from anthropologic and cross-cultural 
research. Ann Intern Med 1978;88
44. Bundesverb and Deutscher Industrie und Handelsunternehmen 
(BDIH) in Germany; Available from https://www.bdih.de/. 
[Last accessed on 12 Jan 2018] 
:251-8. 
45. Soil Association Organic Standard in United Kingdom. Available 
from: https://www.soilassociation.org/certification/. [Last 
accessed on 14 Jan 2018] 
46. Cosmetics Organic Standard (Cosmos) in European Union (EU). 
Available from: https://cosmos-standard.org/. [Last accessed 
on 02 Dec 2017]. 
47. ECOCERT in France. Available from: www.ecocert.in. [Last 
accessed on 10 Nov 2017] 
Jain et al. 
Int J App Pharm, Vol 10, Issue 6, 2018, 47-53 
 
52 
48. National Association for Sustainable Agriculture, Australia 
(NASAA) in Australia. Available from: https://www. 
nasaa.com.au. [Last accessed on 16 Dec 2017] 
49. Istituto per la Certificazione Etica e Ambientale (ICEA) in Italy. 
Available from: http://icea.bio/. [Last accessed on 27 Dec 2017] 
50. InstitutoBiodinâmico de Certificações (IBD) in Brazil. Available 
from: http://ibd.com.br/pt/IbdOrganico.aspx. [Last accessed 
on 13 Nov 2017] 
51. Oregon Tilth in the United States of America; Available from 
https://tilth.org/. [Last accessed on 10 Nov 2017] 
52. Kambooj A. Anaytical Evaluation of Herbal Drugs. Available from: 
http://cdn.intechopen.com/pdfs/32437/InTech-Analytical_ 
evaluation_of_herbal_drugs.pdf. [Last accessed on 21 Jan 2018] 
53. Skoog DA, West DM, Holler FJ. Fundamentals of analytical 
chemistry. 8th
54. 
 ed. Fort Worth: Saunders College Pub; 1996. 
Available from: https://www.pdfdrive.com/title-fundamentals 
-of-analytical-chemistry-8th-edition-student-e4247391.html. 
[Last accessed on 06 Dec 2017]. 
Swartz ME, Krull IS. Analytical method development and 
validation. Marcel Dekker, Inc; New York: 1997. 
55. 
Available from: 
https://pubs.acs.org/doi/abs/10.1021/ja975573z. [Last accessed 
on 10 Nov 2017] 
Food and Drug Administration. Current Good Manufacturing 




[Last accessed on 08 Dec 2017] 
Food and Drug Administration. Current Good Manufacturing 
Practice in Manufacturing, Packaging, Labelling, or Holding 




[Last accessed on 08 Dec 2017] 
International Conference on Harmonisation of Technical 
Requirements for Registration of Pharmaceuticals for Human 
Use, Validation of Analytical Methods: Definitions and 




[Last accessed on 14 Dec 2017] 
Center for Drug Evaluation and Research, Center for Biologicals 
Evaluation and Research, Food and Drug 
Administration. Guidance for Industry-Analytical Procedures 
and Methods Validation-Chemistry, Manufacturing, and 
Controls Documentation Draft Guidance. Department of Health 





tion.pdf [Last accessed on 02 Jan 2018] 
AOAC International. Single Laboratory Validation Acceptance 
Criteria (Chemical Methods) AOAC International; Gaithersburg, 




on 04 Dec 2017] 
AOAC International. Single Laboratory Validation-Generic 




[Last accessed on 07 Nov 2017] 
AOAC International. Method Validation. AOAC International; 
Gaithersbrg, MD; 2010. Available from: http://www.aoac.org/ 
vmeth/omamanual/omamanual.htm. 
62. Chadwick L, Fong H. Herb quality assurance and standardization in 
herb-drug interaction evaluation and documentation. Lam YW, 
Huang SM, Hall SD, editors. New York: Taylor and Francis. Herb 
quality assurance and standardization in herb-drug interaction 
evaluation and documentation; 2006. p. 191–203. 
[Last accessed on 02 Jan 
2018] 
63. Geneva: World Health Organization; World Health Organization. 
Regulatory Situation of Herbal Medicines. A Worldwide Review; 
1998. Available from: http://apps.who.int/iris/handle/ 
10665/63801 [Last accessed on 03 Nov 2017] 
64. Fong HH. Integration of herbal medicine into modern medical 
practices: issues and prospects. Integr Cancer Ther 2002;1:287-93. 
65. Geneva: World Health Organization. WHO Guidelines on Good 
Agricultural and Collection Practices (GACP) for Medicinal 
Plants. 2003 Available from http://apps.who.int/iris/ 
bitstream/handle/10665/42783/9241546271.pdf.jsessionid=
09F846F1069DF6BEC23747D3C280EF8E?sequence=1. [Last 
accessed on 15 Jan 2017] 
66. Geneva: World Health Organization. General Guidelines for 
Methodologies on Research and Evaluation of Traditional 
Medicine. WHO/EDM/TRM; 2000. Available from: http:// 
apps.who.int/iris/handle/10665/66783. [Last accessed on 20 
Dec 2017] 
67. Geneva: World Health Organization. Legal Status of Traditional 
Medicine and Complementary/Alternative Medicine: A 
Worldwide Review. WHO/EDM/TRM; 2001. Available from: 
http://apps.who.int/medicinedocs/en/d/Jh2943e/. [Last accessed 
on 21 Nov 2017] 
68. Nadkarni KM. Indian plants and drugs with their medicinal 
properties and uses.
69. World Health Organization. Guidelines for the regulation of 
herbal medicines in the South-East Asia Region. New Delhi, 
Regional Office for South-East Asia; 2003. Available from: 
 Norton and Co. Madras; 1910. p. 120. 
http://apps.who.int/medicinedocs/en/m/abstract/Js22299en
/. [Last accessed on 05 Nov 2017]. 
70. Skalli S, Soulaymani Bencheikh R. Safety monitoring of herb-
drug interactions: a component of pharmacovigilance. Drug 
Saf 2012;35:785-91. 
71. Shetti S, Kumar CD, Sriwastava NK, Sharma IP. The growing use 
of herbal medicines: Issues relating to adverse reactions and 
challenges in monitoring safety. Front Pharmacol 2014;4:1-10. 
72. Cairo: World Health Organization (WHO), Regional Office for 
the Eastern Mediterranean; World Health Organization. 
Guidelines on minimum requirements for the registration of 
herbal medicinal products in the Eastern Mediterranean 
Region; 2006. Available from: https://www.paho.org/ 
blz/index.php?option=com_docmanandview=downloadandalia
s=223-2006-working-together-for-healthandcategory_slug= 
technical-documentationandItemid=250. [Last accessed on 08 
Nov 2017] 
73. Development of Traditional Medicine in the South-East Asia 
Region. Report of a Regional Consultative Meeting Pyongyang, 
DPR Korea. World Health Organization, Regional Office for 
South-East Asia New Delhi; 2005. Available from: 
http://apps.searo.who.int/PDS_DOCS/B0020.pdf. [Last accessed 
on 10 Jan 2018] 
74. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M, et al. 
Treatment of irritable bowel syndrome with Chinese herbal 
medicine: a randomized controlled trial. JAMA 1998;280:1585-9. 
75. Barens J, Anderson, Phillipson JD, Newall CA. Herbal Medicines. 
Vol. 459: London. Pharmaceutical Press; 2007. p. 1-23. 
76. Quality criteria and standardization of phytopharmaceuticals: 
Can acceptable drug standards be achieved? Drug Inform J 
1994;32:101–10. 
77. Bodeker C, Bodeker G, Ong CK, Grundy CK, Burford G, Shein K. 
WHO global atlas of traditional, complementary and alternative 
medicine. World Health Organization, Geneva. De Smet PAGM; 
2004. Available from: http://apps.who.int/iris/bitstream/ 
handle/10665/43108/9241562862_map.pdf?sequence=1. 
[Last accessed on 23 Dec 2017] 
78. Keller K, Hansel R, Chandler RF, Smet D. Health risks of herbal 
remedies. Drug Saf 1992;13:81-93. 
79. Duke JA, Martinez RV. Overview of herbal quality control. Drug 
Inform J 1994;33:717-24. 
80. European Agency for the Evaluation of Medicinal Products 
(EMEA), London. EMEA. Points to Consider on Good 
Agricultural and Collection Practice for Starting Materials of 
Herbal Origin; 2002. Available from: http://www.ema. 
europa.eu/docs/en_GB/document_library/Other/2009/12/W
C500018057.pdf. [Last accessed on 07 Oct 2017] 
81. Kunle, Folashade O, Egharevba, Omoregie H, Ahmadu, Ochogu 
P. standardization of herbal medicines-a review. Int J Biodiver 
Conserve 2012;4:101-12. 
82. WHO. Basic Tests for Drugs, Pharmaceutical Substances, 
Medicinal Plant Materials, and Dosage Forms. World Health 
Organization, Geneva; 1998. Available from: https://books. 
google.co.in/books?isbn=9241545372. [Last accessed on 26 
Jan 2018] 
83. WHO, General Guidelines for Methodologies on Research and 
Evaluation Traditional Medicine. World Health Organization, 
Jain et al. 
Int J App Pharm, Vol 10, Issue 6, 2018, 47-53 
 
53 
Geneva; 2002. Available from: http://apps.who.int/ medicinedocs/ 
en/d/Jwhozip42e/. [Last accessed on 02 Jan 2018] 
84. EMEA guidelines on Quality of Herbal Medicinal Products/ 
Traditional Medicinal Products, Review. European Agency for the 
Evaluation of Medicinal Products (EMEA), London; 2005. Available 
from: http://www.ema.europa.eu/ docs/en_GB/document_ 
library/Scientific_guideline/2011/09/WC500113209.pdf. [Last 
accessed on 21 Nov 2017] 
85. WHO, Quality Control Methods for Medicinal Plant Materials. 
World Health Organization, Geneva; 1992. Available from: 
http://apps.who.int/iris/handle/10665/41986. [Last accessed 
on 20 Dec 2017] 
86. Adenan MI. Malaysian herbs and herbal products. In A Two and 
Half Day Course of Herbal and Phytochemical Processing, CEPP 
short course notes. Chemical Engineering Pilot Plant, UTM, Skudai; 
2003. Available from: http://eprints.utm.my/id/eprint/ 54831/ 
1/NorAmaizaMohdAminPFChE2015.pdf. [Last accessed on 22 Nov 
2017] 
87. Arif MT. Traditional/Complementary Medicine: The way ahead. 
Med J Malasyia 2002;57:261-4. 
88. Puteh M. In a Two and Half Day course of Herbal and 
Phytochemical Processing, CEPP short course notes. Chemical 
Engineering Pilot Plant, UTM SkudaiJanuary; 2003. Available from: 
http://www.kolmetz.com/pdf/Foo/IJKM_Phytochemical.pdf. [Last 
accessed on 17 Jan 2017] 
89. Wazir SK. promoting the herbal industry in Malaysia: The Malaysia 
Herbal Corporation Initiative. In A Two and Half Day course of 
Herbal and Phytochemical Processing, CEPP short course notes. 
Chemical Engineering Pilot Plant; 2003. Available from: 
http://www.ibd.utm.my/files/PDF/tc_HERBALPHYTO04(L)-
new.pdf. [Last accessed on 12 Jan 2018] 
90. Verma S, Singh SP. Current and future status of herbal 
medicines. Veterinary World 2008;1:347-50. 
91. Padmawar A, Bhadoria U. Phytochemical investigation and 
comparative evaluation of in vitro free radical scavenging 
activity of Triphala and Curcumin. AJMPS 2011;1:9-12. 
92. Ampofo J, Andoh A, Tetteh W, Bello M. Microbiological profile 
of some ghanaian herbal preparations-safety issues and 
implications for the health professions. Open J Med Microbiol 
2012;2:121-30. 
93. Mosihuzzaman M, Choudhary MI. Protocols on safety, efficacy, 
standardization, and documentation of herbal medicine. Pure 
Appl Chem 2008;80:2195-230. 
94. Mukama E. The African herbal industry: constraints and challenges. 
Available from: http://www.academia.edu/3443773/ The_ 
African_herbal_industry_constraints_and_challenges. [Last accessed 
on 08 Jan 2018] 
95. Kamboj A. Analytical evaluation of herbal drugs. Drug Discovery; 
2012. Available from: https://www.intechopen.com/books/drug-
discovery-research-in-pharmacognosy/analytical-evaluation-of-
herbal-drugs. [Last accessed on 03 Jan 2017] 
96. Patkar K. Herbal cosmetics in ancient India. Indian J Plast Surg 
2000;41:134–7. 
97. Galor SW, Benzie IFF. Editors. Herbal medicine: biomolecular 
and clinical aspects. an introduction to its history, usage, 
regulation, current trends, and research needs. 2nd
98. Erah P. Herbal medicines: challenges, a tropical journal of 
pharmaceutical research armstrong NC. Br J Clin Pharmacol 
2002;1:53-4. 
 ed. Boca 
Raton: CRC Press; 2011. 
99. Bauer R, Tittel G. Quality assessment of herbal preparations as 
a precondition of pharmacological and clinical studies. 
Phytomedicine 1996;2:193-8. 
100. Bhattaram VA, Graefe U, Kohlert C, Veit M, Derendorf H. 
Pharmacokinetics and bioavailability of herbal medicinal 
products. Phytomedicine 2002;9 Suppl 3:1-33. 
101. Brevoort P. The U. S. botanical market: an overview. Herbal 
Gram 2002;251:1005-19. 
102. Calixto JB. Efficacy, safety, quality control, marketing and 
regulatory guidelines for herbal medicines (phytotherapeutic 
agents). Braz J Med Biol Res 2000;33:179-89. 
103. Chaudhary Roy, Chandrashekharan M, Mishra S. 
Embryotoxicity and teratogenicity studies of ayurvedic 
contraceptives. J Ethnopharmacol 2001;56:300-1. 
104. Chan K. Some aspects of toxic contaminants in herbal 
medicines. Chemosphere 2003;52:1361-71. 
105. Dahanukar SA, Thatte UM. Current status of Ayurveda in 
phytomedicine. Phytomedicine 1997;4:359-68. 
106. Eisenburg MD, David M. Coincidence in pharmaceutical 
discovery. The impact of biotechnology. Arzneimittel 
Forschung 1995;45:934-9. 
107. Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative 
medicine use in the United States, Results of a follow-up national 
survey. J Am Med Assoc 1998;280:1569-75. 
108. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, 
Delbanco TL. Unconventional medicine in the United States. 
New Engl J Med 1993;328:246-52. 
109. Ernst E, Rand JI, Stevinson C. Complementary therapies for a 
depression-an overview. Arch Gen Psychiat 1998;55:1026-32. 
110. Fisher P, Ward A. Complementary medicine in Europe. Br Med J 
Fugh-Berman 2000;309:107-11. 
111. Grunwald J, Buettel, K. The European phytomedicines market: 
figures, trends, analysis. Herbal Gram 1995;34:60-5. 
112. Marcus D, Grollman A. Botanical medicines-the need for new 
regulations. New Engl J Med 2002:347. 
113. Sivapriya V, Ponnarmadha S, Abdul Azeezand N, Sudarshanadeepa 
V. Novel nanocarriers for ethnopharmacological formulations. Int J 
Appl Pharm 2018;1:26-30. 
114. Alaayedi M, Mahmood H, Saeed A. The enhancement effect of 
castor oil on the permeability of flurbiprofen as a transdermal 
gel. Int J Appl Pharm 2018;10:140-4. 
 
